News Coverage 10.17.19 By: Frank Vinluan Share on Twitter Share on Facebook Share on LinkedIn ArsenalBio Launches With $85M for “Programmable” T Cell Therapies Related Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards Over $1 Million to Five Early Stage Career Researchers Pushing the Boundaries of Cancer Science Announcement, Our Impact PICI-Founded Dispatch Bio Takes on Solid Tumors Announcement CNBC Honors Dr. Karen Knudsen, PICI CEO, as Changemaker
Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards Over $1 Million to Five Early Stage Career Researchers Pushing the Boundaries of Cancer Science